MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1091.64%
Quick Ratio
1091.64%
Cash Ratio
101.15%
Debt to Asset Ratio
23.50%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses and other asset...
Liabilities Breakdown
    • Additionalpaid-incapital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
48,876
114,351
354,725
57,773
Marketable securities
450,285
482,409
359,864
439,616
Prepaid expenses and other assets, current
28,332
19,042
14,294
13,922
Total current assets
527,493
615,802
728,883
511,311
Property and equipment, net
-
-
1,374
1,155
Operating lease right-of-use assets
-
-
1,923
2,036
Prepaid expenses and other assets, noncurrent
-
-
2,553
3,001
Other assets, noncurrent
5,491
5,937
-
-
Total assets
532,984
621,739
734,733
517,503
Accounts payable
14,573
13,909
21,898
17,950
Operating lease liabilities
-
-
549
473
Accrued expenses and other liabilities, current
33,748
31,240
31,008
23,457
Total current liabilities
48,321
45,149
53,455
41,880
Long-term debt
75,228
75,029
74,838
74,648
Operating lease liabilities, noncurrent
-
-
1,919
2,095
Other liabilities, noncurrent
1,677
1,864
-
-
Total liabilities
125,226
122,042
130,212
118,623
Class a common stock, 0.001 par value 500,000,000 shares authorized as of june 30, 2026 and december 31, 2025 71,955,885 and 71,267,429 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
72
72
71
64
Additionalpaid-incapital
1,399,459
1,381,678
1,364,529
1,067,703
Accumulated other comprehensive (loss) income
-403
-156
786
881
Accumulated deficit
-991,370
-881,897
-760,865
-669,768
Total stockholders' equity
407,758
499,697
604,521
398,880
Total liabilities and stockholders' equity
532,984
621,739
734,733
517,503
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$450,285K (-11.31%↓ Y/Y)Cash and cashequivalents$48,876K (-0.50%↓ Y/Y)Prepaid expenses andother assets, current$28,332K (95.03%↑ Y/Y)Total current assets$527,493K (-7.68%↓ Y/Y)Other assets,noncurrent$5,491K Total assets$532,984K (-7.87%↓ Y/Y)Total liabilities andstockholders' equity$532,984K (-7.87%↓ Y/Y)Total stockholders'equity$407,758K (-12.92%↓ Y/Y)Total liabilities$125,226K (13.58%↑ Y/Y)Accumulated deficit-$991,370K (-68.18%↓ Y/Y)Accumulated othercomprehensive (loss) income-$403K (-176.47%↓ Y/Y)Additionalpaid-incapital$1,399,459K (32.38%↑ Y/Y)Long-term debt$75,228K (1.03%↑ Y/Y)Total currentliabilities$48,321K (44.01%↑ Y/Y)Other liabilities,noncurrent$1,677K Class a common stock,0.001 par value...$72K (12.50%↑ Y/Y)Accrued expenses andother liabilities,...$33,748K (72.69%↑ Y/Y)Accounts payable$14,573K (10.76%↑ Y/Y)

Vera Therapeutics, Inc. (VERA)

Vera Therapeutics, Inc. (VERA)